SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-007032
Filing Date
2024-01-24
Accepted
2024-01-24 17:00:05
Documents
1
Period of Report
2024-01-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 14520
  Complete submission text file 0000950170-24-007032.txt   16168
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

IRS No.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CULLINAN ONCOLOGY, LLC ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address
Savill Corrine (Reporting) CIK: 0001837524 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 24557284